TITLE

Molecules and mechanisms of the graft-versus-leukaemia effect

AUTHOR(S)
Bleakley, Marie; R., Riddell, Stanley
PUB. DATE
May 2004
SOURCE
Nature Reviews Cancer;May2004, Vol. 4 Issue 5, p371
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The ability of allogeneic bone-marrow cells and peripheral-blood stem cells to cure leukaemia remains the most striking example of the ability of the human immune system to recognize and destroy tumours. However, harnessing this‘graft-versus-leukaemia’ effect to improve outcome for patients with advanced disease and segregating it from graft-versus-host disease have proven to be key challenges. The recent identification of molecules that are specifically expressed by leukaemic cells and that can be recognized by T cells has indicated that immunological reactivity can be targeted. This anticancer specificity of T cells should soon be routinely incorporated into allogeneic stem-cell transplant regimens to promote tumour eradication.
ACCESSION #
13009190

 

Related Articles

  • Chronic graft-versus-host disease in the era of reduced-intensity conditioning. Subramaniam, D. S.; Fowler, D. H.; Pavletic, S. Z. // Leukemia (08876924);May2007, Vol. 21 Issue 5, p853 

    In the past decade the field of hematopoietic stem cell transplantation has entered a new era with the introduction of reduced intensity conditioning (RIC) regimens. The impact of RIC on the incidence of chronic graft-versus-host disease (GVHD) has not been evaluated systematically. Factors...

  • High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. Passweg, J. R.; Meyer-Monard, S.; Gregor, M.; Favre, G.; Heim, D.; Ebnoether, M.; Tichelli, A.; Gratwohl, A. // Bone Marrow Transplantation;9/1/2002, Vol. 30 Issue 5, p267 

    Presents a study that examined a high stem cell dose and post-transplant donor lymphocyte infusions (DLI) in a T cell-depleted non-myeloablative stem cell transplants (NST) setting. Background on hematopoietic stem cell transplants (HSCT); Importance of alloreactivity of donor immune cells to...

  • Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma. Budak-Alpdogan, T; Sauter, C T; Bailey, C P; Biswas, C S; Panis, M M; Civriz, S; Flomenberg, N; Alpdogan, O // Bone Marrow Transplantation;Aug2013, Vol. 48 Issue 8, p1084 

    Allogeneic hematopoietic SCT (HSCT) has been shown to be an effective treatment option for advanced renal cell cancer (RCC). However, tumor resistance/relapse remains as the main post transplant issue. Therefore, enhancing graft-versus-tumor (GVT) activity without increasing GVHD is critical for...

  • The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: Where do we stand? Sivgin, Serdar; Eser, Bulent // Annals of Hematology;May2013, Vol. 92 Issue 5, p577 

    Iron overload (IO), primarily related to multiple red blood cell transfusions, is a relatively common complication in hematopoietic stem cell transplant (HSCT) recipients. Elevated pretransplant ferritin levels have been reported to increase the risk of non-relapse mortality following HSCT and...

  • Increase of CCR7− CD45RA+ CD8 T cells (TEMRA) in chronic graft-versus-host disease. D'Asaro, M.; Dieli, F.; Caccamo, N.; Musso, M.; Porretto, F.; Salerno, A. // Leukemia (08876924);Mar2006, Vol. 20 Issue 3, p545 

    The article discusses the study regarding the increase of T cells in chronic graft-versus-host disease (cGVHD). A cGVHD still remains as the main factor of long-term outcome and quality of life, among the late effects of hematopoietic stem cell transplantation. Characterized by symptoms similar...

  • Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. Anguille, S; Van Tendeloo, V F; Berneman, Z N // Leukemia (08876924);Oct2012, Vol. 26 Issue 10, p2186 

    The graft-versus-leukemia effect of allogeneic hematopoietic stem cell transplantation (HSCT) has shown that the immune system is capable of eradicating acute myeloid leukemia (AML). This knowledge, along with the identification of the target antigens against which antileukemia immune responses...

  • A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society. Esperou, H; Boiron, J-M; Cayuela, J-M; Blanchet, O; Kuentz, M; Jouet, J-P; Milpied, N; Cahn, J-Y; Faucher, C; Bourhis, J-H; Michallet, M; Tanguy, M-L; Vernant, J-P; Gabert, J; Bordigoni, P; Ifrah, N; Baruchel, A; Dombret, H // Bone Marrow Transplantation;May2003, Vol. 31 Issue 10, p909 

    Summary:Philadelphia chromosome (Ph) acute lymphoblastic leukemia-positive (ALL) is a subgroup of ALL with a poor prognosis. We sought to evaluate the results of allogeneic hematopoietic stem cell transplantation (HSCT) in this situation. From 1992 to 2000, 121 patients with Ph- positive ALL...

  • Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning. Casper, J; Holowiecki, J; Trenschel, R; Wandt, H; Schaefer-Eckart, K; Ruutu, T; Volin, L; Einsele, H; Stuhler, G; Uharek, L; Blau, I; Bornhaeuser, M; Zander, A R; Larsson, K; Markiewicz, M; Giebel, S; Kruzel, T; Mylius, H A; Baumgart, J; Pichlmeier, U // Bone Marrow Transplantation;Sep2012, Vol. 47 Issue 9, p1171 

    An alternative reduced-toxicity conditioning regimen for allogeneic transplantation, based on treosulfan and fludarabine, has recently been identified. The safety and efficacy of this new conditioning regimen has been investigated prospectively in patients with AML. A total number of 75 patients...

  • The immunopathology of thymic GVHD. Krenger, Werner; Holl�nder, Georg // Seminars in Immunopathology;2008, Vol. 30 Issue 4, p439 

    The clinical success of allogeneic hematopoietic stem cell transplantation (HSCT) depends on the appropriate reconstitution of the host�s immune system. While recovery of T-cell immunity may occur in transplant recipients via both thymus-dependent and thymus-independent pathways, the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics